cygnus
GLP-1 Apprentice
As I understood it initially this was just yet another drug in Eli Lilly's pipeline, however I came across a rumor that it is an oral investigation which would make me think this might be a possible oral retatrutide (or similar given GGG triple agonist pathways). Right now it is in Phase 1, with no results to assess that I could find on a cursory search.
Obviously this would be enormous provided it pans out, but something to watch closely over the next couple of months.
Obviously this would be enormous provided it pans out, but something to watch closely over the next couple of months.
